Viridian Therapeutics Inc
NASDAQ:VRDN

Watchlist Manager
Viridian Therapeutics Inc Logo
Viridian Therapeutics Inc
NASDAQ:VRDN
Watchlist
Price: 22.43 USD -12.76% Market Closed
Market Cap: 1.7B USD
Have any thoughts about
Viridian Therapeutics Inc?
Write Note

Viridian Therapeutics Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Viridian Therapeutics Inc
Additional Paid In Capital Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Viridian Therapeutics Inc
NASDAQ:VRDN
Additional Paid In Capital
$1.2B
CAGR 3-Years
65%
CAGR 5-Years
45%
CAGR 10-Years
41%
Abbvie Inc
NYSE:ABBV
Additional Paid In Capital
$21.2B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Additional Paid In Capital
$12.7B
CAGR 3-Years
17%
CAGR 5-Years
24%
CAGR 10-Years
18%

See Also

What is Viridian Therapeutics Inc's Additional Paid In Capital?
Additional Paid In Capital
1.2B USD

Based on the financial report for Jun 30, 2024, Viridian Therapeutics Inc's Additional Paid In Capital amounts to 1.2B USD.

What is Viridian Therapeutics Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
41%

Over the last year, the Additional Paid In Capital growth was 48%. The average annual Additional Paid In Capital growth rates for Viridian Therapeutics Inc have been 65% over the past three years , 45% over the past five years , and 41% over the past ten years .

Back to Top